New products
Medtronic reports real-world findings for cardiac ablation systems
Medtronic released real-world evidence from its registry supporting the performance of its cardiac ablation systems in patients with atrial fibrillation and ventricular tachycardia. The findings reflect clinical outcomes from deployed ablation platforms and contribute to the vendor's clinical validation portfolio for rhythm-management technologies.
The source
This brief is a MedIndexer summary of reporting by Medical Device Network. To read the full story, head to the source.
Read the full story at Medical Device Network